chr16-75629481-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005548.3(KARS1):āc.1485A>Gā(p.Ile495Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00063 in 1,614,200 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005548.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KARS1 | NM_005548.3 | c.1485A>G | p.Ile495Met | missense_variant | Exon 12 of 14 | ENST00000302445.8 | NP_005539.1 | |
KARS1 | NM_001130089.2 | c.1569A>G | p.Ile523Met | missense_variant | Exon 13 of 15 | NP_001123561.1 | ||
KARS1 | NM_001378148.1 | c.1017A>G | p.Ile339Met | missense_variant | Exon 12 of 14 | NP_001365077.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152272Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000513 AC: 129AN: 251468Hom.: 0 AF XY: 0.000530 AC XY: 72AN XY: 135910
GnomAD4 exome AF: 0.000663 AC: 969AN: 1461810Hom.: 1 Cov.: 32 AF XY: 0.000672 AC XY: 489AN XY: 727216
GnomAD4 genome AF: 0.000315 AC: 48AN: 152390Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74518
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1
- -
- -
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 523 of the KARS protein (p.Ile523Met). This variant is present in population databases (rs144274136, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with KARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 228757). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KARS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
not specified Uncertain:2
Variant classified as Uncertain Significance - Favor Benign. The p.Ile523Met var iant in KARS has not been previously reported in individuals with hearing loss, but has been identified in 0.12% (79/66738) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs144274136 ). Computational prediction tools and conservation analysis do not provide stro ng support for or against an impact to the protein. In summary, while the clinic al significance of the p.Ile523Met variant is uncertain, its frequency in the ge neral population suggests that it is more likely to be benign. -
The c.1569A>G (p.I523M) alteration is located in exon 13 (coding exon 12) of the KARS gene. This alteration results from a A to G substitution at nucleotide position 1569, causing the isoleucine (I) at amino acid position 523 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hearing impairment Uncertain:1
PP3_Supporting -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at